Fundraising Fox
/Companies
Sign in

BiomeSense

Chicago, US · Founded 2018 · Delaware corporation · 17 employees on LinkedIn · 7 known investors

Find your way into BiomeSense

Sign up to find every way you can get introduced to BiomeSense

  • Your email: who you already know at BiomeSense, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BiomeSense team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up free →Already have an account? Log in

BiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.

AI & Machine LearningBiotechDigital HealthHardwareHealthtech

Founders & leadership

KH
Kevin HonakerCEO

Board

DN
Dylan NicholsTechnical Operations Lead
AHAshley Hartman
Ashley HartmanBoard directorManaging Partner at Bluestein Ventures
VR
Vanessa Rollings GiannisBoard director
ABAndrew Bluestein
Andrew BluesteinBoard directorCo-Founder & Managing Partner at Bluestein Ventures
OE
Orhan ErtughrulBoard director

Investors · 7

Chicago Early Growth Ventures (CEGV)listed by Chicago Early Growth Ventures (CEGV)Chicago
ECP Growthlisted by ECP GrowthGreenwichvia Morgan Ratcliffe · inferred

How we know: ECP Growth's portfolio page · the VCSheet dataset · Not right? Tell us

IrishAngelslisted by IrishAngelsSan Francisco · $250K – $350K

How we know: IrishAngels's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Overton Venture Capitallisted by Overton Venture CapitalNew York · $100K – $300K

How we know: the VCSheet dataset · Not right? Tell us

Seaside Ventureslisted by Seaside VenturesBoulder · $250K
Service Provider Capitallisted by Service Provider CapitalVail

Reported raises · per SEC filings

Form D private placements

$15.7M disclosed across 3 rounds · 2019–2025

▶$7.1MraisedNov 2025 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dylan NicholsDirector
  • Ashley HartmanDirector
  • Kevin HonakerExecutive Officer, Director
  • Vanessa Rollings GiannisDirector
  • Andrew BluesteinDirector
Offering amount
$7.3M
Amount sold
$7.1M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedDec 2023 · 33 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dylan NicholsDirector
  • Parikshit SharmaDirector
  • Vanessa Rollings GiannisDirector
  • Kevin HonakerExecutive Officer, Director
  • Andrew BluesteinDirector
Offering amount
$6.5M
Amount sold
$6.2M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin HonakerExecutive Officer, Director
  • Dylan NicholsDirector
  • Orhan ErtughrulDirector
Offering amount
$2.5M
Amount sold
$2.4M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

BiomeBiome makes Taiga, a smart hydroponic living wall with onboard sensors, automated irrigation, and lighting that automates indoor plant care, along with the Halo grow light, plant supplements, and a companion app to monitor and control the system. It sells soil-free, fully grown living walls for home consumers, shipped from its indoor vertical greenhouse in Oakland, CA.
Biome AnalyticsBiome provides analytics tools for healthcare leaders, focused on improving cardiovascular care outcomes and reducing operational inefficiency. It serves hospitals and cardiac care centers, offering data-driven products including the Biome Performance Network for clinical and operational decision-making.
Viome Life SciencesViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.
AgbiomeUS agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
BIOHMBIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations. Its formula combines bacteria, fungi, and a digestive enzyme intended to support digestive health.

Companies working in the same space as BiomeSense.

Frequently asked questions

What does BiomeSense do?
BiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.
Who are BiomeSense's investors?
BiomeSense's investors include Bluestein Ventures, Chicago Early Growth Ventures (CEGV), ECP Growth, IrishAngels, Overton Venture Capital, Seaside Ventures, Service Provider Capital.
How much funding has BiomeSense raised?
BiomeSense has disclosed $15.7M raised across 3 rounds.
Where is BiomeSense headquartered?
BiomeSense is headquartered in Chicago, US.